- Home
- PENN vs FOLD Comparison
PENN vs FOLD Comparison
Compare PENN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- FOLD
- Stock Information
- Founded
- PENN 1972
- FOLD 2002
- Country
- PENN United States
- FOLD United States
- Employees
- PENN N/A
- FOLD N/A
- Industry
- PENN Hotels/Resorts
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- FOLD Health Care
- Exchange
- PENN Nasdaq
- FOLD Nasdaq
- Market Cap
- PENN 2.8B
- FOLD 2.9B
- IPO Year
- PENN 1994
- FOLD 2007
- Fundamental
- Price
- PENN $18.06
- FOLD $5.99
- Analyst Decision
- PENN Buy
- FOLD Strong Buy
- Analyst Count
- PENN 19
- FOLD 10
- Target Price
- PENN $22.94
- FOLD $26.89
- AVG Volume (30 Days)
- PENN 3.5M
- FOLD 4.1M
- Earning Date
- PENN 08-07-2025
- FOLD 07-31-2025
- Dividend Yield
- PENN N/A
- FOLD N/A
- EPS Growth
- PENN N/A
- FOLD N/A
- EPS
- PENN N/A
- FOLD N/A
- Revenue
- PENN $6,643,700,000.00
- FOLD $571,160,000.00
- Revenue This Year
- PENN $7.80
- FOLD $19.97
- Revenue Next Year
- PENN $5.57
- FOLD $22.92
- P/E Ratio
- PENN N/A
- FOLD N/A
- Revenue Growth
- PENN 5.51
- FOLD 25.35
- 52 Week Low
- PENN $13.25
- FOLD $5.51
- 52 Week High
- PENN $23.08
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- PENN 50.42
- FOLD 46.51
- Support Level
- PENN $18.26
- FOLD $6.06
- Resistance Level
- PENN $19.31
- FOLD $6.40
- Average True Range (ATR)
- PENN 0.56
- FOLD 0.27
- MACD
- PENN -0.08
- FOLD -0.01
- Stochastic Oscillator
- PENN 42.66
- FOLD 12.36
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.